CALL 1 (855) LH-WORKS

Theradome Provides Next-Generation, Clinical Strength Laser Technology for Safe, Effective Hair Restoration at Home

Your Hair Loss Treatment Costs Over Ten Years

hair growth treatment - FDA approved

What is Theradome?

You’ve been losing hair for a long time. Up until now, your options have been limited to expensive hair restoration surgery, inconvenient visits to laser hair clinics, costly prescription drugs, messy topical creams, and ineffective LED devices that don’t penetrate the scalp with sufficient energy. The Theradome LH80 PRO has managed to cut the costs of clinical strength Laser Phototherapy while maximizing its benefits for FDA - cleared and affordable hair rejuvenation in the comfort of your own home.

Learn More
hair growth treatment - FDA approved

How Does It Work?

Cold laser therapy has had over 50 years to develop into cutting edge technology. Our full coverage helmet makes use of 80 proprietary lasers that are optimized for the purposes of hair growth and can reach all problem areas. Unlike devices manufactured with LEDs, our 678-nm laser light penetrates your scalp and can effectively reach the base of hair follicles during a 20-minute treatment window. Stimulation at the cellular level ensures adequate energy is absorbed to regrow, strengthen, and rejuvenate your hair.

Learn More
hair growth treatment - FDA approved

What to Expect?

Hair loss doesn’t occur overnight and neither does hair growth. With only twice-a-week, 20-minute sessions at home, you can start paving the way to a full head of healthy hair. Clinical trials have shown that over time, hair loss can be reversed with the Theradome LH80 PRO. Most of our patients that choose to adhere to our recommended regimen and instructions experience a decrease of shedding, an increase of hair growth, and a doubling of hair diameter, overall giving them thicker, more vibrant hair.

Learn More
Elle Magazine

FEATURED ARTICLE

THICK, LUSTROUS HAIR COULD BE ONE LASER APPOINTMENT AWAY

ELLE MAGAZINE | JAN 16, 2015 | BY MOLLY LANGMUIR | SEE ARTICLE